The impact of dissection of station 9 on survival and the necessity of pulmonary ligament division during upper lobectomy for lung cancer

Acta Chir Belg. 2023 Apr;123(2):148-155. doi: 10.1080/00015458.2021.1958189. Epub 2021 Jul 26.

Abstract

Background: We conducted this study to investigate the need for dissection of station 9 lymph nodes during upper lobectomy for non-small-cell lung cancer (NSCLC) and to find out the operative results of inferior pulmonary ligament division.

Methods: A total of 840 patients who underwent upper lobectomy for NSCLC between January 2007 and June 2020 were evaluated retrospectively. The patients were separated into two groups - those having undergone lymph node dissection of station 9 and inferior pulmonary ligament dissection (Group I) and those who did not (Group II). In these groups, the prognostic value of station 9 lymph nodes and postoperative effects (drainage time, prolonged air leak, dead space and length of hospital stay) of ligament division or preservation were analyzed.

Results: The number of patients with station 9 lymph node metastasis was only one (0.1%) and that was multi-station pN2 disease. Station 9 lymph nodes were found in 675 (80.4%) patients, while 22 (2.6%) patients had no lymph nodes in the dissected material. In the other 143 (17%) patients, the inferior pulmonary ligament and station 9 were not dissected. While 5-year survival was 64.9% in 697 patients of Group I, it was 61.3% in 143 patients of Group II (p = 0.56). There was no statistically significant difference between the groups in postoperative effects of ligament division or preservation.

Conclusions: In upper lobectomies, status of station 9 does not have a significant impact on patients' survival and lymph node staging. Additionally, preservation or division of the inferior pulmonary ligament has no significant advantage or disadvantage.

Keywords: MLND; Non-small cell lung cancer; pulmonary ligament; staging; station 9 lymph nodes; upper lobectomy.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Humans
  • Ligaments
  • Lung Neoplasms* / pathology
  • Lymph Node Excision / methods
  • Lymphatic Metastasis
  • Neoplasm Staging
  • Pneumonectomy / methods
  • Retrospective Studies